FRDD

Forensically-Relevant Drug Database

NPS Discover

Description

Preferred Drug Name

N-Pyrrolidino Ethylene Isotonitazene

Brief Description

N-Pyrrolidino ethylene isotonitazene is a synthetic opioid bearing structural resemblance to other nitazene analogues (e.g., N-pyrrolidino isotonitazene, isotonitazene, ethylene etonitazene). NPyrrolidino ethylene isotonitazene differs from currently known nitazene analogues with a lengthened linker between the benzyl and benzimidazole groups.1 N-Pyrrolidino ethylene isotonitazene was first identified by our laboratory in March 2025 and confirmed after acquiring standard reference material.


Nomenclature

Formal Name (IUPAC)

2-[2-(4-isopropoxyphenyl)ethyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole

Synonyms

Ethylene Isotonitazepyne, Ethylene N-Pyrrolidino Isotonitazene

Chemistry

Chemical Formula

C24H30N4O3

Molecular Mass

422.50

Molecular Ion

422

Exact Mass

423.2391

InChI Key

BCRJRRWYLQWRPJ-UHFFFAOYSA-N

GCMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Drug Materials: Dilution in methanol or acid / base extraction

Drug Standards: Dilution in methanol

Instrument:Agilent 5975 Series GC/MSD System
Column:Agilent J&W DB-1 (12 m x 200 µm x 0.33 µm)
Carrier Gas:Helium (Flow: 1.46 mL/min)
Temperatures:

Injection Port: 265 °C

Transfer Line: 300 °C

MS Source: 230 °C

MS Quad: 150 °C

Oven Program: 50 °C for 0 min, 30 °C/min to 340 °C for 2.3 min

Injection Parameters:Injection Type: Splitless, Injection Volume: 1 µL
MS Parameters:Mass Scan Range: 40-550 m/z

 

Images

Fragments

84
107
42

HRMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Toxicology Samples: Liquid-liquid extraction

Drug Materials: Dilution of sample in mobile phase

Instrument:

Sciex TripleTOF® 5600+, Shimadzu Nexera XR UHPLC

Sciex X500R, Sciex ExionLC

Column:Phenomenex® Kinetex C18 (50 mm x 3.0 mm, 2.6 µm)
Mobile Phase:

A: Ammonium formate (10 mM, pH 3.0)

B: Methanol/acetonitrile (50:50)

Flow rate: 0.4 mL/min

Gradient:Initial: 95A:5B; 5A:95B over 13 min; 95A:5B at 15.5 min
Temperatures:

Autosampler: 15 °C

Column Oven: 30 °C

Source Heater: 600 °C

Injection Parameters:Injection Volume: 10 µL
QTOF Parameters:

TOF MS Scan Range: 100-510 Da

Precursor Isolation: SWATH® acquisition (27 windows)

Fragmentation: Collison Energy Spread (35±15 eV)

MS/MS Scan Range: 50-510 Da

 

Images

Fragments

98.0958
423.2378
56.0493

Drug Origins and Uses

Drug Origins and Uses

Illicit, Synthetic

Biological Effects

Biological Effects

Analgesic, Sedative/Hypnotic

Target Receptor or Neurotransmitter

Target Receptor or Neurotransmitter

MOR

Pharmacodynamics

Pharmacodynamics

Agonist

Drug Control

US Controlled Substance Schedule

Not Controlled


Pharmacology Literature

Source

Neuropharmacology

Title

Pharmacology of newly identified nitazene variants reveals structural determinants of affinity, potency, selectivity for mu opioid receptors

Reference Link


Published January 27, 2026